{"gene":"ADPRH","run_date":"2026-06-09T22:02:42","timeline":{"discoveries":[{"year":2005,"finding":"ARH1 (ADPRH) is a 39-kDa ADP-ribosylarginine hydrolase that cleaves the N-glycosidic bond of mono-ADP-ribosylated arginine residues on proteins, releasing free ADP-ribose and regenerating unmodified protein. Its activity is enhanced by Mg2+. Critical vicinal acidic amino acids required for catalytic activity were identified by mutagenesis.","method":"In vitro enzymatic assay with recombinant protein; mutagenesis of catalytic residues; substrate specificity analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with recombinant enzyme, mutagenesis of active-site residues, multiple substrate specificity tests, replicated across multiple papers","pmids":["16278211"],"is_preprint":false},{"year":2007,"finding":"ARH1 (ADPRH) counteracts cholera toxin-mediated ADP-ribosylation of the Gsα protein in vivo. ADPRH-knockout cells and mice showed greater intoxication (higher ADP-ribosylarginine content, greater Gsα modification, increased fluid accumulation in intestinal loops) than wild-type, and overexpression of wild-type ADPRH in knockout cells reduced these effects.","method":"ADPRH knockout mouse model; overexpression rescue; measurement of ADP-ribosylarginine content and Gsα modification; intestinal loop fluid accumulation assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO mouse with specific phenotypic readout, rescue by re-expression of wild-type enzyme, multiple orthogonal readouts","pmids":["17526733"],"is_preprint":false},{"year":2011,"finding":"ARH1 deficiency in mice leads to spontaneous development of lymphomas, adenocarcinomas, and metastases, establishing ARH1 as a tumor suppressor. ARH1-null and heterozygous mouse embryonic fibroblasts showed higher proliferation rates and formed tumors in nude mice. Loss of heterozygosity of the remaining ARH1 allele was documented in all tumors from heterozygous mice.","method":"ARH1 knockout and heterozygous mouse models; tumor incidence analysis; MEF proliferation assays; nude mouse xenograft; loss-of-heterozygosity analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO/Het mouse model with defined tumor phenotype, LOH documentation, MEF xenograft, multiple orthogonal methods","pmids":["21697277"],"is_preprint":false},{"year":2014,"finding":"Comprehensive structural analysis of ARH1 and ARH3 by crystallography revealed that the two enzymes have distinct substrate requirements driven by diverged adenosine ribose moiety binding, while the active sites harboring the distal ribose closely resemble each other. Structural basis for selective inhibition of ARH3 (but not ARH1) by ADP-HPD and arginine-ADP-ribose was elucidated.","method":"X-ray crystallography; biochemical inhibition assays with ADP-ribose analogues","journal":"Cell chemical biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures with functional biochemical validation, single lab but multiple orthogonal methods","pmids":["30472116"],"is_preprint":false},{"year":2009,"finding":"Human ARH1 (ADPRH) was crystallized in complex with K+ and ADP, yielding diffracting crystals at 1.9 Å resolution. The presence of K+ was required for well-diffracting crystals, indicating a structural role for K+ in the enzyme.","method":"Recombinant protein expression in E. coli, X-ray crystallography, X-ray fluorescence analysis","journal":"Acta crystallographica. Section F, Structural biology and crystallization communications","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — crystal structure obtained at 1.9 Å, single lab, no functional mutagenesis follow-up reported in abstract","pmids":["19407395"],"is_preprint":false},{"year":2018,"finding":"ARH1 cleaves ADP-ribosylated TRIM72 (tripartite motif-containing protein 72) on arginine residues in the myocardium. ARH1-deficient mice developed cardiomyopathy with myocardial fibrosis, decreased myocardial function, and increased susceptibility to ischemia/reperfusion injury. ARH1, ART1 (the writing enzyme), and TRIM72 were found in multiple co-immunoprecipitated complexes from mouse heart lysates. ARH1 knockdown in C2C12 myocytes increased ADP-ribosylation of TRIM72 and delayed wound healing.","method":"ARH1-knockout mouse model; co-immunoprecipitation from heart lysates; ARH1 knockdown in C2C12 myocytes; scratch wound assay; mutant TRIM72 (R207K, R260K) functional analysis","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mouse with cardiac phenotype, co-IP identifying complex, substrate identification via mutant TRIM72, cell-based wound healing assay — multiple orthogonal methods","pmids":["30429362"],"is_preprint":false},{"year":2015,"finding":"ARH1 mutations found in tumors from ARH1 heterozygous mice encode proteins with reduced enzymatic activity. MEFs transformed with ARH1 mutant genes showed altered proliferation rates, anchorage-independent colony growth, and tumorigenesis in nude mice in proportion to the degree of hydrolase activity loss, establishing a direct link between ARH1 catalytic activity and tumor suppression.","method":"Enzymatic activity assays of ARH1 mutant proteins; MEF transformation; soft-agar colony assay; nude mouse xenograft","journal":"Oncogenesis","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple mutants with graded enzymatic activity correlated to tumorigenesis, multiple orthogonal cellular assays","pmids":["26029825"],"is_preprint":false},{"year":2019,"finding":"ARH1 hydrolyzes α-NAD+ (but not β-NAD+) in a stereospecific reaction, in addition to its established α-ADP-ribosyl-arginine hydrolase activity. This activity is shared with ARH3 and macrodomain proteins, revealing a broader role in cellular NAD+ metabolism.","method":"In vitro enzymatic assay with recombinant ARH1, ARH3, and macrodomain proteins; substrate specificity with α-NAD+ vs β-NAD+; crystal structures of Af1521 and ARH3 with bound ADP-ribose","journal":"ACS chemical biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with recombinant enzyme, stereospecificity demonstrated, supported by structural data, single lab","pmids":["31599159"],"is_preprint":false},{"year":2011,"finding":"ARH1 hydrolyzes O-acetyl-ADP-ribose (OAADPr) and poly(ADP-ribose), in addition to ADP-ribose-arginine. Mechanistic analysis revealed that ARH1-catalyzed hydrolysis of OAADPr involves nucleophilic attack at the C-1″ position, consistent with cleavage of a 1″-O linkage. A postulated 1″-OAADPr isomer was identified at alkaline pH.","method":"In vitro enzymatic assay; pH-dependence studies; H218O isotope labeling with mass spectrometric analysis; IC50 measurements with ADP-ribose analogues","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — isotope labeling experiment establishing reaction mechanism, multiple substrate analyses, single lab with multiple orthogonal methods","pmids":["21498885"],"is_preprint":false},{"year":2018,"finding":"Female ARH1-knockout mice show greater sensitivity to cholera toxin than male ARH1-KO mice, with higher ADP-ribosylated Gsα protein levels and increased ADP-ribosylarginine content in intestinal epithelial cells, revealing a gender-dependent role of ARH1 in regulating cholera toxin-mediated ADP-ribosylation.","method":"ARH1 knockout mouse model; intestinal loop fluid accumulation assay; measurement of ADP-ribosylarginine content; ADP-ribosyl Gαs level quantification; comparison of male vs female mice","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse model with biochemical readouts, two orthogonal measurements (ADP-ribosylarginine content and Gsα modification), single lab","pmids":["30500844"],"is_preprint":false},{"year":2005,"finding":"The ADPRH (ARH1) gene spans approximately 9 kilobases with four exons and three introns. Promoter analysis identified potent stimulatory (−119 to −89) and inhibitory (−161 to −119) elements. An Sp1-binding GC-box element (−107 to −95) positively regulates ADPRH transcription, as demonstrated by Sp1/Sp3 binding (EMSA) and Sp1 trans-activation in Drosophila SL2 cells lacking endogenous Sp1.","method":"Genomic cloning; Northern analysis; transient transfection with truncated promoter constructs; electrophoretic mobility-shift assay (EMSA); supershift assay; co-transfection in Drosophila SL2 cells","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cell line transfections, EMSA with supershift, functional rescue in Sp1-null cells, single lab","pmids":["15893437"],"is_preprint":false},{"year":2002,"finding":"Retroviral expression of wild-type ARH1 in transformed lymphocytes from autosomal recessive hypercholesterolemia patients restored LDL receptor internalization, as demonstrated by uptake and degradation of 125I-labeled LDL and confocal microscopy, establishing ARH1 as a functional adaptor required for LDL receptor-dependent LDL internalization in lymphocytes and macrophages.","method":"Retroviral expression of ARH1; 125I-LDL uptake and degradation assay; confocal microscopy","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional rescue by re-expression, two orthogonal readouts (biochemical and imaging), single lab","pmids":["12464675"],"is_preprint":false},{"year":2022,"finding":"ARH1 is a cytosolic protein ubiquitously expressed in mammalian tissues. In vivo confirmed substrates include Gαs (ADP-ribosylated by cholera toxin) and TRIM72 (ADP-ribosylated by ART1), with ARH1 cleaving the ADP-ribose-arginine bond on these proteins. ARH1 deficiency leads to increased ADP-ribosylation of TRIM72 following ischemia/reperfusion injury.","method":"Subcellular fractionation (cytosolic localization); in vivo substrate identification by ARH1-KO mouse studies; proteomic identification of ADP-ribosylarginine substrates","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse in vivo substrate validation, subcellular fractionation, review consolidating multiple prior experiments from the same group","pmids":["36497109"],"is_preprint":false},{"year":2023,"finding":"ARTC1 (the arginine-specific ADP-ribosyltransferase) and ARH1 function in the same ADP-ribosylation cycle. Artc1/Arh1 double-KO MEFs showed decreased tumorigenesis in nude mice compared to Arh1-KO MEFs, and Artc1-KO recipient mice showed decreased xenograft tumor growth with CD8+ T cell and macrophage infiltration and necroptosis, establishing ARTC1 as the writing enzyme counterpart to ARH1 in the same pathway.","method":"Double-KO mouse model (Artc1/Arh1); nude mouse xenograft; immunophenotyping of tumor infiltrate; genetic epistasis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — genetic epistasis via double-KO with xenograft readout, preprint not yet peer-reviewed, single lab","pmids":["36945646"],"is_preprint":true}],"current_model":"ADPRH (ARH1) is a cytosolic 39-kDa enzyme that cleaves the α-anomeric ADP-ribose–arginine bond on mono-ADP-ribosylated proteins (including Gαs and TRIM72), as well as O-acetyl-ADP-ribose and α-NAD+, thereby reversing arginine-specific ADP-ribosylation catalyzed by ARTC1 and bacterial toxins such as cholera toxin; loss of ARH1 activity leads to accumulation of ADP-ribosylated proteins, increased tumorigenesis (functioning as a tumor suppressor via LOH), cardiomyopathy with impaired membrane repair, and enhanced susceptibility to cholera toxin intoxication."},"narrative":{"mechanistic_narrative":"ADPRH (ARH1) is a cytosolic, ubiquitously expressed enzyme that reverses arginine-specific mono-ADP-ribosylation by hydrolyzing the N-glycosidic ADP-ribose–arginine bond on modified proteins, regenerating unmodified protein and releasing free ADP-ribose [PMID:16278211, PMID:36497109]. Catalysis requires vicinal acidic active-site residues and is enhanced by Mg2+, with crystallographic analysis showing that ARH1 binds K+ as a structural ion and that its adenosine-ribose binding diverges from the related ARH3 to dictate distinct substrate specificity [PMID:16278211, PMID:19407395, PMID:30472116]. Beyond protein substrates, ARH1 hydrolyzes O-acetyl-ADP-ribose via nucleophilic attack at the C-1″ position and stereospecifically cleaves α-NAD+ but not β-NAD+, linking it to broader NAD+ metabolism [PMID:21498885, PMID:31599159]. ARH1 operates as the eraser in an ADP-ribosylation cycle whose writers are bacterial cholera toxin and the cellular transferase ARTC1/ART1: it counteracts cholera toxin-mediated ADP-ribosylation of Gαs, with ARH1-deficient mice showing greater intoxication and fluid accumulation, and it cleaves ADP-ribosylated TRIM72 in myocardium, where ARH1, ART1, and TRIM72 form co-immunoprecipitating complexes [PMID:17526733, PMID:30429362, PMID:36497109]. Loss of ARH1 produces distinct pathologies across these axes: cardiomyopathy with myocardial fibrosis, impaired membrane repair, and increased ischemia/reperfusion injury [PMID:30429362], and tumorigenesis—ARH1 acts as a tumor suppressor, with knockout/heterozygous mice developing lymphomas and adenocarcinomas, loss of heterozygosity in tumors, and tumorigenicity that scales inversely with retained hydrolase activity, placing ARTC1 as the epistatic writer counterpart in this cancer pathway [PMID:21697277, PMID:26029825, PMID:36945646].","teleology":[{"year":2005,"claim":"Establishing that ARH1 is an enzyme reversing arginine ADP-ribosylation answered what biochemical activity the gene encodes and defined its catalytic requirements.","evidence":"In vitro enzymatic assay with recombinant protein, active-site mutagenesis, and substrate specificity analysis","pmids":["16278211"],"confidence":"High","gaps":["Did not establish in vivo physiological substrates","Structural basis of catalysis not yet resolved"]},{"year":2009,"claim":"Crystallization with K+ and ADP provided the first high-resolution structural view and revealed a structural role for K+ in the enzyme.","evidence":"X-ray crystallography at 1.9 Å with X-ray fluorescence analysis of recombinant protein","pmids":["19407395"],"confidence":"Medium","gaps":["No functional mutagenesis follow-up on K+ site","Substrate-bound conformation not captured"]},{"year":2007,"claim":"Demonstrating that ARH1 counteracts cholera toxin ADP-ribosylation of Gαs in vivo connected the in vitro activity to a physiological host-defense role against bacterial toxin.","evidence":"ADPRH-knockout mouse model with overexpression rescue, ADP-ribosylarginine and Gαs quantification, intestinal loop fluid assay","pmids":["17526733"],"confidence":"High","gaps":["Did not address endogenous (non-toxin) substrates","Tissue-specific contributions not dissected"]},{"year":2011,"claim":"Identifying ARH1 as a tumor suppressor whose loss drives spontaneous tumors and LOH established a cancer-relevant function beyond toxin defense.","evidence":"Knockout/heterozygous mouse tumor incidence, MEF proliferation, nude mouse xenograft, loss-of-heterozygosity analysis","pmids":["21697277"],"confidence":"High","gaps":["Endogenous substrate driving transformation not identified","Mechanism linking ADP-ribose accumulation to proliferation unresolved"]},{"year":2011,"claim":"Showing ARH1 hydrolyzes O-acetyl-ADP-ribose and poly(ADP-ribose) broadened its substrate range and defined the reaction chemistry at the C-1″ position.","evidence":"In vitro assays with pH dependence, H218O isotope labeling/mass spectrometry, and IC50 with ADP-ribose analogues","pmids":["21498885"],"confidence":"High","gaps":["Physiological relevance of OAADPr/PAR hydrolysis in cells not established","Relative in vivo flux through each substrate unknown"]},{"year":2015,"claim":"Correlating graded hydrolase activity loss in tumor-derived ARH1 mutants with tumorigenicity established that catalytic activity is directly responsible for tumor suppression.","evidence":"Enzymatic assays of mutant proteins, MEF transformation, soft-agar colony assay, nude mouse xenograft","pmids":["26029825"],"confidence":"High","gaps":["Specific ADP-ribosylated target mediating suppression not pinned down","Signaling pathway downstream of substrate accumulation unknown"]},{"year":2018,"claim":"Identifying TRIM72 as a cardiac substrate and showing cardiomyopathy in ARH1-deficient mice extended the eraser function to membrane repair physiology.","evidence":"Knockout mouse cardiac phenotyping, co-immunoprecipitation of ARH1/ART1/TRIM72 complexes, C2C12 knockdown scratch-wound assay, mutant TRIM72 analysis","pmids":["30429362"],"confidence":"High","gaps":["How TRIM72 ADP-ribosylation impairs membrane repair mechanistically not fully defined","Whether other cardiac substrates contribute unknown"]},{"year":2018,"claim":"Revealing greater cholera toxin sensitivity in female ARH1-KO mice introduced a sex-dependent dimension to ARH1 toxin regulation.","evidence":"Knockout mouse intestinal loop assay with ADP-ribosylarginine and Gαs quantification comparing male and female mice","pmids":["30500844"],"confidence":"Medium","gaps":["Molecular basis of sex difference not identified","Single lab, biochemical readouts only"]},{"year":2019,"claim":"Demonstrating stereospecific α-NAD+ hydrolysis positioned ARH1 within cellular NAD+ metabolism alongside ARH3 and macrodomains.","evidence":"In vitro enzymatic assays with recombinant enzymes comparing α- vs β-NAD+, supported by structural data","pmids":["31599159"],"confidence":"High","gaps":["In vivo contribution to NAD+ pools not quantified","Cellular source of α-NAD+ substrate unclear"]},{"year":2018,"claim":"Comparative crystallography of ARH1 and ARH3 explained their divergent substrate specificity and the selective inhibition of ARH3.","evidence":"X-ray crystallography with biochemical inhibition assays using ADP-HPD and arginine-ADP-ribose","pmids":["30472116"],"confidence":"High","gaps":["No selective ARH1 inhibitor defined","Catalytic mechanism transitions not directly visualized"]},{"year":2023,"claim":"Genetic epistasis placing ARTC1 as the writer counterpart to ARH1 closed the loop on the ADP-ribosylation cycle underlying tumorigenesis and revealed immune involvement.","evidence":"Artc1/Arh1 double-KO MEFs, nude mouse xenografts, tumor immunophenotyping (preprint)","pmids":["36945646"],"confidence":"Medium","gaps":["Preprint not peer-reviewed","Shared endogenous substrate of the ARTC1/ARH1 cycle in tumors not defined","Mechanism of immune infiltration and necroptosis unresolved"]},{"year":null,"claim":"The endogenous protein substrate(s) whose persistent ADP-ribosylation mediates ARH1's tumor-suppressor and metabolic functions remain unidentified.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No proteome-wide map of physiological ARH1 substrates in transformation","Downstream signaling from substrate accumulation to phenotype not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,7,8]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,5]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[7,8]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[12]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[7]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,2]}],"complexes":[],"partners":["ART1","TRIM72","GNAS","ARTC1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P54922","full_name":"ADP-ribosylhydrolase ARH1","aliases":["ADP-ribose-L-arginine cleaving enzyme","[Protein ADP-ribosylarginine] hydrolase","ADP-ribosylarginine hydrolase","hARH1"],"length_aa":357,"mass_kda":39.5,"function":"Specifically acts as an arginine mono-ADP-ribosylhydrolase by mediating the removal of mono-ADP-ribose attached to arginine residues on proteins","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P54922/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ADPRH","classification":"Not Classified","n_dependent_lines":12,"n_total_lines":1208,"dependency_fraction":0.009933774834437087},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ADPRH","total_profiled":1310},"omim":[{"mim_id":"603081","title":"ADP-RIBOSYLARGININE HYDROLASE; ADPRH","url":"https://www.omim.org/entry/603081"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nuclear membrane","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ADPRH"},"hgnc":{"alias_symbol":["ARH1"],"prev_symbol":[]},"alphafold":{"accession":"P54922","domains":[{"cath_id":"1.10.4080.10","chopping":"2-350","consensus_level":"high","plddt":98.5153,"start":2,"end":350}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P54922","model_url":"https://alphafold.ebi.ac.uk/files/AF-P54922-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P54922-F1-predicted_aligned_error_v6.png","plddt_mean":98.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ADPRH","jax_strain_url":"https://www.jax.org/strain/search?query=ADPRH"},"sequence":{"accession":"P54922","fasta_url":"https://rest.uniprot.org/uniprotkb/P54922.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P54922/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P54922"}},"corpus_meta":[{"pmid":"8107887","id":"PMC_8107887","title":"A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling.","date":"1994","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8107887","citation_count":412,"is_preprint":false},{"pmid":"8011288","id":"PMC_8011288","title":"Signal transduction by the B cell antigen receptor and its coreceptors.","date":"1994","source":"Annual review of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8011288","citation_count":373,"is_preprint":false},{"pmid":"16278211","id":"PMC_16278211","title":"Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16278211","citation_count":248,"is_preprint":false},{"pmid":"7530763","id":"PMC_7530763","title":"TCR/CD3 coupling to Fas-based cytotoxicity.","date":"1995","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7530763","citation_count":210,"is_preprint":false},{"pmid":"25358379","id":"PMC_25358379","title":"Functional reconstitution of mitochondrial Fe/S cluster synthesis on Isu1 reveals the involvement of ferredoxin.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25358379","citation_count":142,"is_preprint":false},{"pmid":"8168489","id":"PMC_8168489","title":"Analysis of Ig-alpha-tyrosine kinase interaction reveals two levels of binding specificity and tyrosine phosphorylated Ig-alpha stimulation of Fyn activity.","date":"1994","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8168489","citation_count":135,"is_preprint":false},{"pmid":"8183901","id":"PMC_8183901","title":"Distinct p53/56lyn and p59fyn domains associate with nonphosphorylated and phosphorylated Ig-alpha.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8183901","citation_count":126,"is_preprint":false},{"pmid":"15335855","id":"PMC_15335855","title":"B-cell antigen receptor motifs have redundant signalling capabilities and bind the tyrosine kinases PTK72, Lyn and Fyn.","date":"1993","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/15335855","citation_count":107,"is_preprint":false},{"pmid":"11897284","id":"PMC_11897284","title":"Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis.","date":"2002","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11897284","citation_count":107,"is_preprint":false},{"pmid":"17075046","id":"PMC_17075046","title":"The 39-kDa poly(ADP-ribose) glycohydrolase ARH3 hydrolyzes O-acetyl-ADP-ribose, a product of the Sir2 family of acetyl-histone deacetylases.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17075046","citation_count":105,"is_preprint":false},{"pmid":"7718892","id":"PMC_7718892","title":"Identification of signaling motifs within human Fc gamma RIIa and Fc gamma RIIb isoforms.","date":"1995","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/7718892","citation_count":100,"is_preprint":false},{"pmid":"21944752","id":"PMC_21944752","title":"Coenzyme Q biosynthesis: Coq6 is required for the C5-hydroxylation reaction and substrate analogs rescue Coq6 deficiency.","date":"2011","source":"Chemistry & biology","url":"https://pubmed.ncbi.nlm.nih.gov/21944752","citation_count":97,"is_preprint":false},{"pmid":"21296186","id":"PMC_21296186","title":"Expression of the human atypical kinase ADCK3 rescues coenzyme Q biosynthesis and phosphorylation of Coq polypeptides in yeast coq8 mutants.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/21296186","citation_count":96,"is_preprint":false},{"pmid":"20534343","id":"PMC_20534343","title":"Involvement of mitochondrial ferredoxin and para-aminobenzoic acid in yeast coenzyme Q biosynthesis.","date":"2010","source":"Chemistry & biology","url":"https://pubmed.ncbi.nlm.nih.gov/20534343","citation_count":92,"is_preprint":false},{"pmid":"1418703","id":"PMC_1418703","title":"Signal transduction by T- and B-cell antigen receptors: converging structures and concepts.","date":"1992","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1418703","citation_count":83,"is_preprint":false},{"pmid":"33693930","id":"PMC_33693930","title":"ADP-ribosylation of RNA and DNA: from in vitro characterization to in vivo function.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/33693930","citation_count":78,"is_preprint":false},{"pmid":"24746921","id":"PMC_24746921","title":"Structure and function of the ARH family of ADP-ribosyl-acceptor hydrolases.","date":"2014","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/24746921","citation_count":72,"is_preprint":false},{"pmid":"28965846","id":"PMC_28965846","title":"FDXR Mutations Cause Sensorial Neuropathies and Expand the Spectrum of Mitochondrial Fe-S-Synthesis Diseases.","date":"2017","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28965846","citation_count":71,"is_preprint":false},{"pmid":"25631044","id":"PMC_25631044","title":"Identification of Coq11, a new coenzyme Q biosynthetic protein in the CoQ-synthome in Saccharomyces cerevisiae.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25631044","citation_count":65,"is_preprint":false},{"pmid":"31077613","id":"PMC_31077613","title":"Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.","date":"2019","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/31077613","citation_count":64,"is_preprint":false},{"pmid":"30472116","id":"PMC_30472116","title":"(ADP-ribosyl)hydrolases: Structural Basis for Differential Substrate Recognition and Inhibition.","date":"2018","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/30472116","citation_count":62,"is_preprint":false},{"pmid":"12464675","id":"PMC_12464675","title":"Restoration of LDL receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1.","date":"2002","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12464675","citation_count":59,"is_preprint":false},{"pmid":"17526733","id":"PMC_17526733","title":"Enhanced sensitivity to cholera toxin in ADP-ribosylarginine hydrolase-deficient mice.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17526733","citation_count":58,"is_preprint":false},{"pmid":"29228209","id":"PMC_29228209","title":"CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells.","date":"2018","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/29228209","citation_count":58,"is_preprint":false},{"pmid":"10375636","id":"PMC_10375636","title":"YAH1 of Saccharomyces cerevisiae: a new essential gene that codes for a protein homologous to human adrenodoxin.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10375636","citation_count":53,"is_preprint":false},{"pmid":"24835913","id":"PMC_24835913","title":"Efficient production of pullulan using rice hull hydrolysate by adaptive laboratory evolution of Aureobasidium pullulans.","date":"2014","source":"Bioresource technology","url":"https://pubmed.ncbi.nlm.nih.gov/24835913","citation_count":46,"is_preprint":false},{"pmid":"9727014","id":"PMC_9727014","title":"Characterization of recombinant adrenodoxin reductase homologue (Arh1p) from yeast. Implication in in vitro cytochrome p45011beta monooxygenase system.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9727014","citation_count":44,"is_preprint":false},{"pmid":"9818721","id":"PMC_9818721","title":"ARH1 of Saccharomyces cerevisiae: a new essential gene that codes for a protein homologous to the human adrenodoxin reductase.","date":"1998","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9818721","citation_count":43,"is_preprint":false},{"pmid":"21498885","id":"PMC_21498885","title":"Hydrolysis of O-acetyl-ADP-ribose isomers by ADP-ribosylhydrolase 3.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21498885","citation_count":42,"is_preprint":false},{"pmid":"21697277","id":"PMC_21697277","title":"ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis.","date":"2011","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21697277","citation_count":41,"is_preprint":false},{"pmid":"23871723","id":"PMC_23871723","title":"Imprinted chromatin around DIRAS3 regulates alternative splicing of GNG12-AS1, a long noncoding RNA.","date":"2013","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23871723","citation_count":34,"is_preprint":false},{"pmid":"23793341","id":"PMC_23793341","title":"Design and characterization of an efficient CYP105A1-based whole-cell biocatalyst for the conversion of resin acid diterpenoids in permeabilized Escherichia coli.","date":"2013","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/23793341","citation_count":34,"is_preprint":false},{"pmid":"10677305","id":"PMC_10677305","title":"A new locus for autosomal recessive hypercholesterolemia maps to human chromosome 15q25-q26.","date":"2000","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10677305","citation_count":33,"is_preprint":false},{"pmid":"25077680","id":"PMC_25077680","title":"EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer.","date":"2015","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/25077680","citation_count":32,"is_preprint":false},{"pmid":"18399988","id":"PMC_18399988","title":"The endogenous adrenodoxin reductase-like flavoprotein arh1 supports heterologous cytochrome P450-dependent substrate conversions in Schizosaccharomyces pombe.","date":"2008","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/18399988","citation_count":28,"is_preprint":false},{"pmid":"31599159","id":"PMC_31599159","title":"The ARH and Macrodomain Families of α-ADP-ribose-acceptor Hydrolases Catalyze α-NAD Hydrolysis.","date":"2019","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/31599159","citation_count":25,"is_preprint":false},{"pmid":"15211518","id":"PMC_15211518","title":"Predictive reconstruction of the mitochondrial iron-sulfur cluster assembly metabolism: I. The role of the protein pair ferredoxin-ferredoxin reductase (Yah1-Arh1).","date":"2004","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/15211518","citation_count":23,"is_preprint":false},{"pmid":"27090906","id":"PMC_27090906","title":"Functional Role of ADP-Ribosyl-Acceptor Hydrolase 3 in poly(ADP-Ribose) Polymerase-1 Response to Oxidative Stress.","date":"2016","source":"Current protein & peptide science","url":"https://pubmed.ncbi.nlm.nih.gov/27090906","citation_count":23,"is_preprint":false},{"pmid":"30429362","id":"PMC_30429362","title":"Role of a TRIM72 ADP-ribosylation cycle in myocardial injury and membrane repair.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/30429362","citation_count":22,"is_preprint":false},{"pmid":"19477448","id":"PMC_19477448","title":"Prevalence and clinical features of heterozygous carriers of autosomal recessive hypercholesterolemia in Sardinia.","date":"2009","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/19477448","citation_count":21,"is_preprint":false},{"pmid":"26029825","id":"PMC_26029825","title":"Mutations of the functional ARH1 allele in tumors from ARH1 heterozygous mice and cells affect ARH1 catalytic activity, cell proliferation and tumorigenesis.","date":"2015","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/26029825","citation_count":18,"is_preprint":false},{"pmid":"7797258","id":"PMC_7797258","title":"Differential binding activity of ARH1/TAM motifs.","date":"1995","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/7797258","citation_count":18,"is_preprint":false},{"pmid":"30267646","id":"PMC_30267646","title":"Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways.","date":"2018","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30267646","citation_count":18,"is_preprint":false},{"pmid":"7806507","id":"PMC_7806507","title":"Reconstitution of CD3 zeta coupling to calcium mobilization via genetic complementation.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7806507","citation_count":16,"is_preprint":false},{"pmid":"22202177","id":"PMC_22202177","title":"CYP105A1 mediated 3-hydroxylation of glimepiride and glibenclamide using a recombinant Bacillus megaterium whole-cell catalyst.","date":"2011","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/22202177","citation_count":15,"is_preprint":false},{"pmid":"30500844","id":"PMC_30500844","title":"Enhanced sensitivity to cholera toxin in female ADP-ribosylarginine hydrolase (ARH1)-deficient mice.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30500844","citation_count":13,"is_preprint":false},{"pmid":"36389681","id":"PMC_36389681","title":"Differences of macrophages in the tumor microenvironment as an underlying key factor in glioma patients.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36389681","citation_count":13,"is_preprint":false},{"pmid":"38647746","id":"PMC_38647746","title":"Light-driven progesterone production by InP-(M. neoaurum) biohybrid system.","date":"2022","source":"Bioresources and bioprocessing","url":"https://pubmed.ncbi.nlm.nih.gov/38647746","citation_count":13,"is_preprint":false},{"pmid":"36497109","id":"PMC_36497109","title":"ARH Family of ADP-Ribose-Acceptor Hydrolases.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36497109","citation_count":12,"is_preprint":false},{"pmid":"14717060","id":"PMC_14717060","title":"Clinical and biochemical characterisation of patients with autosomal recessive hypercholesterolemia (ARH).","date":"2003","source":"Nutrition, metabolism, and cardiovascular diseases : NMCD","url":"https://pubmed.ncbi.nlm.nih.gov/14717060","citation_count":12,"is_preprint":false},{"pmid":"35380161","id":"PMC_35380161","title":"Are PARPs promiscuous?","date":"2022","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/35380161","citation_count":10,"is_preprint":false},{"pmid":"39862739","id":"PMC_39862739","title":"A promising future for breast cancer therapy with hydroxamic acid-based histone deacetylase inhibitors.","date":"2025","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39862739","citation_count":10,"is_preprint":false},{"pmid":"17408500","id":"PMC_17408500","title":"In silico pathway reconstruction: Iron-sulfur cluster biogenesis in Saccharomyces cerevisiae.","date":"2007","source":"BMC systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17408500","citation_count":10,"is_preprint":false},{"pmid":"29153781","id":"PMC_29153781","title":"Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred.","date":"2017","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/29153781","citation_count":9,"is_preprint":false},{"pmid":"21536008","id":"PMC_21536008","title":"Structural and thermodynamic characterization of the adrenodoxin-like domain of the electron-transfer protein Etp1 from Schizosaccharomyces pombe.","date":"2011","source":"Journal of inorganic biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21536008","citation_count":9,"is_preprint":false},{"pmid":"32092898","id":"PMC_32092898","title":"ARH1 in Health and Disease.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32092898","citation_count":8,"is_preprint":false},{"pmid":"19407395","id":"PMC_19407395","title":"Cloning, expression, purification and crystallization as well as X-ray fluorescence and preliminary X-ray diffraction analyses of human ADP-ribosylhydrolase 1.","date":"2009","source":"Acta crystallographica. Section F, Structural biology and crystallization communications","url":"https://pubmed.ncbi.nlm.nih.gov/19407395","citation_count":8,"is_preprint":false},{"pmid":"36945431","id":"PMC_36945431","title":"Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/36945431","citation_count":7,"is_preprint":false},{"pmid":"33838635","id":"PMC_33838635","title":"Catalytic Properties of Flavocytochrome c Sulfide Dehydrogenase from Haloalkaliphilic Bacterium Thioalkalivibrio paradoxus.","date":"2021","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/33838635","citation_count":6,"is_preprint":false},{"pmid":"30097869","id":"PMC_30097869","title":"Mono-ADP-Ribosylhydrolase Assays.","date":"2018","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/30097869","citation_count":4,"is_preprint":false},{"pmid":"15893437","id":"PMC_15893437","title":"Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.","date":"2005","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/15893437","citation_count":2,"is_preprint":false},{"pmid":"27997612","id":"PMC_27997612","title":"Signatures of Crested Ibis MHC Revealed by Recombination Screening and Short-Reads Assembly Strategy.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27997612","citation_count":2,"is_preprint":false},{"pmid":"38141230","id":"PMC_38141230","title":"Activation of Coq6p, a FAD Monooxygenase Involved in Coenzyme Q Biosynthesis, by Adrenodoxin Reductase/Ferredoxin.","date":"2024","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/38141230","citation_count":1,"is_preprint":false},{"pmid":"36945646","id":"PMC_36945646","title":"Mono-ADP-ribosyltransferase 1 ( Artc1 )-deficiency decreases tumorigenesis, increases inflammation, decreases cardiac contractility, and reduces survival.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/36945646","citation_count":0,"is_preprint":false},{"pmid":"36798189","id":"PMC_36798189","title":"ADP-ribose-acceptor hydrolase 2 ( Arh2 ) deficiency results in cardiac dysfunction, tumorigenesis, inflammation, and decreased survival.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/36798189","citation_count":0,"is_preprint":false},{"pmid":"31429849","id":"PMC_31429849","title":"Metabolic response to Parkinson's disease recapitulated by the haploinsufficient diploid yeast cells hemizygous for the adrenodoxin reductase gene.","date":"2019","source":"Molecular omics","url":"https://pubmed.ncbi.nlm.nih.gov/31429849","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":35905,"output_tokens":3811,"usd":0.08244,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11700,"output_tokens":3654,"usd":0.074925,"stage2_stop_reason":"end_turn"},"total_usd":0.157365,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"ARH1 (ADPRH) is a 39-kDa ADP-ribosylarginine hydrolase that cleaves the N-glycosidic bond of mono-ADP-ribosylated arginine residues on proteins, releasing free ADP-ribose and regenerating unmodified protein. Its activity is enhanced by Mg2+. Critical vicinal acidic amino acids required for catalytic activity were identified by mutagenesis.\",\n      \"method\": \"In vitro enzymatic assay with recombinant protein; mutagenesis of catalytic residues; substrate specificity analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with recombinant enzyme, mutagenesis of active-site residues, multiple substrate specificity tests, replicated across multiple papers\",\n      \"pmids\": [\"16278211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ARH1 (ADPRH) counteracts cholera toxin-mediated ADP-ribosylation of the Gsα protein in vivo. ADPRH-knockout cells and mice showed greater intoxication (higher ADP-ribosylarginine content, greater Gsα modification, increased fluid accumulation in intestinal loops) than wild-type, and overexpression of wild-type ADPRH in knockout cells reduced these effects.\",\n      \"method\": \"ADPRH knockout mouse model; overexpression rescue; measurement of ADP-ribosylarginine content and Gsα modification; intestinal loop fluid accumulation assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO mouse with specific phenotypic readout, rescue by re-expression of wild-type enzyme, multiple orthogonal readouts\",\n      \"pmids\": [\"17526733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ARH1 deficiency in mice leads to spontaneous development of lymphomas, adenocarcinomas, and metastases, establishing ARH1 as a tumor suppressor. ARH1-null and heterozygous mouse embryonic fibroblasts showed higher proliferation rates and formed tumors in nude mice. Loss of heterozygosity of the remaining ARH1 allele was documented in all tumors from heterozygous mice.\",\n      \"method\": \"ARH1 knockout and heterozygous mouse models; tumor incidence analysis; MEF proliferation assays; nude mouse xenograft; loss-of-heterozygosity analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO/Het mouse model with defined tumor phenotype, LOH documentation, MEF xenograft, multiple orthogonal methods\",\n      \"pmids\": [\"21697277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Comprehensive structural analysis of ARH1 and ARH3 by crystallography revealed that the two enzymes have distinct substrate requirements driven by diverged adenosine ribose moiety binding, while the active sites harboring the distal ribose closely resemble each other. Structural basis for selective inhibition of ARH3 (but not ARH1) by ADP-HPD and arginine-ADP-ribose was elucidated.\",\n      \"method\": \"X-ray crystallography; biochemical inhibition assays with ADP-ribose analogues\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures with functional biochemical validation, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"30472116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Human ARH1 (ADPRH) was crystallized in complex with K+ and ADP, yielding diffracting crystals at 1.9 Å resolution. The presence of K+ was required for well-diffracting crystals, indicating a structural role for K+ in the enzyme.\",\n      \"method\": \"Recombinant protein expression in E. coli, X-ray crystallography, X-ray fluorescence analysis\",\n      \"journal\": \"Acta crystallographica. Section F, Structural biology and crystallization communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — crystal structure obtained at 1.9 Å, single lab, no functional mutagenesis follow-up reported in abstract\",\n      \"pmids\": [\"19407395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ARH1 cleaves ADP-ribosylated TRIM72 (tripartite motif-containing protein 72) on arginine residues in the myocardium. ARH1-deficient mice developed cardiomyopathy with myocardial fibrosis, decreased myocardial function, and increased susceptibility to ischemia/reperfusion injury. ARH1, ART1 (the writing enzyme), and TRIM72 were found in multiple co-immunoprecipitated complexes from mouse heart lysates. ARH1 knockdown in C2C12 myocytes increased ADP-ribosylation of TRIM72 and delayed wound healing.\",\n      \"method\": \"ARH1-knockout mouse model; co-immunoprecipitation from heart lysates; ARH1 knockdown in C2C12 myocytes; scratch wound assay; mutant TRIM72 (R207K, R260K) functional analysis\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mouse with cardiac phenotype, co-IP identifying complex, substrate identification via mutant TRIM72, cell-based wound healing assay — multiple orthogonal methods\",\n      \"pmids\": [\"30429362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ARH1 mutations found in tumors from ARH1 heterozygous mice encode proteins with reduced enzymatic activity. MEFs transformed with ARH1 mutant genes showed altered proliferation rates, anchorage-independent colony growth, and tumorigenesis in nude mice in proportion to the degree of hydrolase activity loss, establishing a direct link between ARH1 catalytic activity and tumor suppression.\",\n      \"method\": \"Enzymatic activity assays of ARH1 mutant proteins; MEF transformation; soft-agar colony assay; nude mouse xenograft\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple mutants with graded enzymatic activity correlated to tumorigenesis, multiple orthogonal cellular assays\",\n      \"pmids\": [\"26029825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ARH1 hydrolyzes α-NAD+ (but not β-NAD+) in a stereospecific reaction, in addition to its established α-ADP-ribosyl-arginine hydrolase activity. This activity is shared with ARH3 and macrodomain proteins, revealing a broader role in cellular NAD+ metabolism.\",\n      \"method\": \"In vitro enzymatic assay with recombinant ARH1, ARH3, and macrodomain proteins; substrate specificity with α-NAD+ vs β-NAD+; crystal structures of Af1521 and ARH3 with bound ADP-ribose\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with recombinant enzyme, stereospecificity demonstrated, supported by structural data, single lab\",\n      \"pmids\": [\"31599159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ARH1 hydrolyzes O-acetyl-ADP-ribose (OAADPr) and poly(ADP-ribose), in addition to ADP-ribose-arginine. Mechanistic analysis revealed that ARH1-catalyzed hydrolysis of OAADPr involves nucleophilic attack at the C-1″ position, consistent with cleavage of a 1″-O linkage. A postulated 1″-OAADPr isomer was identified at alkaline pH.\",\n      \"method\": \"In vitro enzymatic assay; pH-dependence studies; H218O isotope labeling with mass spectrometric analysis; IC50 measurements with ADP-ribose analogues\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — isotope labeling experiment establishing reaction mechanism, multiple substrate analyses, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"21498885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Female ARH1-knockout mice show greater sensitivity to cholera toxin than male ARH1-KO mice, with higher ADP-ribosylated Gsα protein levels and increased ADP-ribosylarginine content in intestinal epithelial cells, revealing a gender-dependent role of ARH1 in regulating cholera toxin-mediated ADP-ribosylation.\",\n      \"method\": \"ARH1 knockout mouse model; intestinal loop fluid accumulation assay; measurement of ADP-ribosylarginine content; ADP-ribosyl Gαs level quantification; comparison of male vs female mice\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse model with biochemical readouts, two orthogonal measurements (ADP-ribosylarginine content and Gsα modification), single lab\",\n      \"pmids\": [\"30500844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The ADPRH (ARH1) gene spans approximately 9 kilobases with four exons and three introns. Promoter analysis identified potent stimulatory (−119 to −89) and inhibitory (−161 to −119) elements. An Sp1-binding GC-box element (−107 to −95) positively regulates ADPRH transcription, as demonstrated by Sp1/Sp3 binding (EMSA) and Sp1 trans-activation in Drosophila SL2 cells lacking endogenous Sp1.\",\n      \"method\": \"Genomic cloning; Northern analysis; transient transfection with truncated promoter constructs; electrophoretic mobility-shift assay (EMSA); supershift assay; co-transfection in Drosophila SL2 cells\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell line transfections, EMSA with supershift, functional rescue in Sp1-null cells, single lab\",\n      \"pmids\": [\"15893437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Retroviral expression of wild-type ARH1 in transformed lymphocytes from autosomal recessive hypercholesterolemia patients restored LDL receptor internalization, as demonstrated by uptake and degradation of 125I-labeled LDL and confocal microscopy, establishing ARH1 as a functional adaptor required for LDL receptor-dependent LDL internalization in lymphocytes and macrophages.\",\n      \"method\": \"Retroviral expression of ARH1; 125I-LDL uptake and degradation assay; confocal microscopy\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional rescue by re-expression, two orthogonal readouts (biochemical and imaging), single lab\",\n      \"pmids\": [\"12464675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ARH1 is a cytosolic protein ubiquitously expressed in mammalian tissues. In vivo confirmed substrates include Gαs (ADP-ribosylated by cholera toxin) and TRIM72 (ADP-ribosylated by ART1), with ARH1 cleaving the ADP-ribose-arginine bond on these proteins. ARH1 deficiency leads to increased ADP-ribosylation of TRIM72 following ischemia/reperfusion injury.\",\n      \"method\": \"Subcellular fractionation (cytosolic localization); in vivo substrate identification by ARH1-KO mouse studies; proteomic identification of ADP-ribosylarginine substrates\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse in vivo substrate validation, subcellular fractionation, review consolidating multiple prior experiments from the same group\",\n      \"pmids\": [\"36497109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ARTC1 (the arginine-specific ADP-ribosyltransferase) and ARH1 function in the same ADP-ribosylation cycle. Artc1/Arh1 double-KO MEFs showed decreased tumorigenesis in nude mice compared to Arh1-KO MEFs, and Artc1-KO recipient mice showed decreased xenograft tumor growth with CD8+ T cell and macrophage infiltration and necroptosis, establishing ARTC1 as the writing enzyme counterpart to ARH1 in the same pathway.\",\n      \"method\": \"Double-KO mouse model (Artc1/Arh1); nude mouse xenograft; immunophenotyping of tumor infiltrate; genetic epistasis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genetic epistasis via double-KO with xenograft readout, preprint not yet peer-reviewed, single lab\",\n      \"pmids\": [\"36945646\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"ADPRH (ARH1) is a cytosolic 39-kDa enzyme that cleaves the α-anomeric ADP-ribose–arginine bond on mono-ADP-ribosylated proteins (including Gαs and TRIM72), as well as O-acetyl-ADP-ribose and α-NAD+, thereby reversing arginine-specific ADP-ribosylation catalyzed by ARTC1 and bacterial toxins such as cholera toxin; loss of ARH1 activity leads to accumulation of ADP-ribosylated proteins, increased tumorigenesis (functioning as a tumor suppressor via LOH), cardiomyopathy with impaired membrane repair, and enhanced susceptibility to cholera toxin intoxication.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ADPRH (ARH1) is a cytosolic, ubiquitously expressed enzyme that reverses arginine-specific mono-ADP-ribosylation by hydrolyzing the N-glycosidic ADP-ribose\\u2013arginine bond on modified proteins, regenerating unmodified protein and releasing free ADP-ribose [#0, #12]. Catalysis requires vicinal acidic active-site residues and is enhanced by Mg2+, with crystallographic analysis showing that ARH1 binds K+ as a structural ion and that its adenosine-ribose binding diverges from the related ARH3 to dictate distinct substrate specificity [#0, #4, #3]. Beyond protein substrates, ARH1 hydrolyzes O-acetyl-ADP-ribose via nucleophilic attack at the C-1\\u2033 position and stereospecifically cleaves \\u03b1-NAD+ but not \\u03b2-NAD+, linking it to broader NAD+ metabolism [#8, #7]. ARH1 operates as the eraser in an ADP-ribosylation cycle whose writers are bacterial cholera toxin and the cellular transferase ARTC1/ART1: it counteracts cholera toxin-mediated ADP-ribosylation of G\\u03b1s, with ARH1-deficient mice showing greater intoxication and fluid accumulation, and it cleaves ADP-ribosylated TRIM72 in myocardium, where ARH1, ART1, and TRIM72 form co-immunoprecipitating complexes [#1, #5, #12]. Loss of ARH1 produces distinct pathologies across these axes: cardiomyopathy with myocardial fibrosis, impaired membrane repair, and increased ischemia/reperfusion injury [#5], and tumorigenesis\\u2014ARH1 acts as a tumor suppressor, with knockout/heterozygous mice developing lymphomas and adenocarcinomas, loss of heterozygosity in tumors, and tumorigenicity that scales inversely with retained hydrolase activity, placing ARTC1 as the epistatic writer counterpart in this cancer pathway [#2, #6, #13].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Establishing that ARH1 is an enzyme reversing arginine ADP-ribosylation answered what biochemical activity the gene encodes and defined its catalytic requirements.\",\n      \"evidence\": \"In vitro enzymatic assay with recombinant protein, active-site mutagenesis, and substrate specificity analysis\",\n      \"pmids\": [\"16278211\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish in vivo physiological substrates\", \"Structural basis of catalysis not yet resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Crystallization with K+ and ADP provided the first high-resolution structural view and revealed a structural role for K+ in the enzyme.\",\n      \"evidence\": \"X-ray crystallography at 1.9 \\u00c5 with X-ray fluorescence analysis of recombinant protein\",\n      \"pmids\": [\"19407395\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional mutagenesis follow-up on K+ site\", \"Substrate-bound conformation not captured\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating that ARH1 counteracts cholera toxin ADP-ribosylation of G\\u03b1s in vivo connected the in vitro activity to a physiological host-defense role against bacterial toxin.\",\n      \"evidence\": \"ADPRH-knockout mouse model with overexpression rescue, ADP-ribosylarginine and G\\u03b1s quantification, intestinal loop fluid assay\",\n      \"pmids\": [\"17526733\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address endogenous (non-toxin) substrates\", \"Tissue-specific contributions not dissected\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identifying ARH1 as a tumor suppressor whose loss drives spontaneous tumors and LOH established a cancer-relevant function beyond toxin defense.\",\n      \"evidence\": \"Knockout/heterozygous mouse tumor incidence, MEF proliferation, nude mouse xenograft, loss-of-heterozygosity analysis\",\n      \"pmids\": [\"21697277\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous substrate driving transformation not identified\", \"Mechanism linking ADP-ribose accumulation to proliferation unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showing ARH1 hydrolyzes O-acetyl-ADP-ribose and poly(ADP-ribose) broadened its substrate range and defined the reaction chemistry at the C-1\\u2033 position.\",\n      \"evidence\": \"In vitro assays with pH dependence, H218O isotope labeling/mass spectrometry, and IC50 with ADP-ribose analogues\",\n      \"pmids\": [\"21498885\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of OAADPr/PAR hydrolysis in cells not established\", \"Relative in vivo flux through each substrate unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Correlating graded hydrolase activity loss in tumor-derived ARH1 mutants with tumorigenicity established that catalytic activity is directly responsible for tumor suppression.\",\n      \"evidence\": \"Enzymatic assays of mutant proteins, MEF transformation, soft-agar colony assay, nude mouse xenograft\",\n      \"pmids\": [\"26029825\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific ADP-ribosylated target mediating suppression not pinned down\", \"Signaling pathway downstream of substrate accumulation unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identifying TRIM72 as a cardiac substrate and showing cardiomyopathy in ARH1-deficient mice extended the eraser function to membrane repair physiology.\",\n      \"evidence\": \"Knockout mouse cardiac phenotyping, co-immunoprecipitation of ARH1/ART1/TRIM72 complexes, C2C12 knockdown scratch-wound assay, mutant TRIM72 analysis\",\n      \"pmids\": [\"30429362\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TRIM72 ADP-ribosylation impairs membrane repair mechanistically not fully defined\", \"Whether other cardiac substrates contribute unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revealing greater cholera toxin sensitivity in female ARH1-KO mice introduced a sex-dependent dimension to ARH1 toxin regulation.\",\n      \"evidence\": \"Knockout mouse intestinal loop assay with ADP-ribosylarginine and G\\u03b1s quantification comparing male and female mice\",\n      \"pmids\": [\"30500844\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of sex difference not identified\", \"Single lab, biochemical readouts only\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating stereospecific \\u03b1-NAD+ hydrolysis positioned ARH1 within cellular NAD+ metabolism alongside ARH3 and macrodomains.\",\n      \"evidence\": \"In vitro enzymatic assays with recombinant enzymes comparing \\u03b1- vs \\u03b2-NAD+, supported by structural data\",\n      \"pmids\": [\"31599159\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo contribution to NAD+ pools not quantified\", \"Cellular source of \\u03b1-NAD+ substrate unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Comparative crystallography of ARH1 and ARH3 explained their divergent substrate specificity and the selective inhibition of ARH3.\",\n      \"evidence\": \"X-ray crystallography with biochemical inhibition assays using ADP-HPD and arginine-ADP-ribose\",\n      \"pmids\": [\"30472116\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No selective ARH1 inhibitor defined\", \"Catalytic mechanism transitions not directly visualized\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Genetic epistasis placing ARTC1 as the writer counterpart to ARH1 closed the loop on the ADP-ribosylation cycle underlying tumorigenesis and revealed immune involvement.\",\n      \"evidence\": \"Artc1/Arh1 double-KO MEFs, nude mouse xenografts, tumor immunophenotyping (preprint)\",\n      \"pmids\": [\"36945646\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint not peer-reviewed\", \"Shared endogenous substrate of the ARTC1/ARH1 cycle in tumors not defined\", \"Mechanism of immune infiltration and necroptosis unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The endogenous protein substrate(s) whose persistent ADP-ribosylation mediates ARH1's tumor-suppressor and metabolic functions remain unidentified.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No proteome-wide map of physiological ARH1 substrates in transformation\", \"Downstream signaling from substrate accumulation to phenotype not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 7, 8]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 5]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ART1\", \"TRIM72\", \"GNAS\", \"ARTC1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":5,"faith_total":5,"faith_pct":100.0}}